Vesugen is a Khavinson short peptide bioregulator, the tripeptide Lys-Glu-Asp (KED), aimed at vascular tissue. It is proposed to support healthy endothelial and vascular gene expression, covering the vascular track in the three-track model of aging (cellular, immune, vascular) that the Khavinson bioregulators are organized around. Evidence is largely Russian bioregulator research, so the interest here is early-stage.
- A Khavinson tripeptide, Lys-Glu-Asp (KED), specifically targeted at vascular tissue.researchdosing
- Proposed to support healthy endothelial and vascular gene expression and function.researchdosing
- Fills the vascular slot in the Khavinson cellular/immune/vascular triad, alongside Epithalon and Thymalin.thepeptidereport
- Evidence base is largely Russian bioregulator research with limited Western RCTs, and effects described are subtle and preliminary.PubMed